Adam Kittai, MD, Ohio State University, Columbus, OH discusses his recently published review in Current Hematologic Malignancy Reports on the relevance of prognostic factors in the era of targeted therapies in chronic lymphocytic leukemia (CLL). This interview took place at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.